WO2021114713A1 - Solution de lyse cellulaire, kit et application - Google Patents

Solution de lyse cellulaire, kit et application Download PDF

Info

Publication number
WO2021114713A1
WO2021114713A1 PCT/CN2020/110066 CN2020110066W WO2021114713A1 WO 2021114713 A1 WO2021114713 A1 WO 2021114713A1 CN 2020110066 W CN2020110066 W CN 2020110066W WO 2021114713 A1 WO2021114713 A1 WO 2021114713A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
cell
kit
library
lysis
Prior art date
Application number
PCT/CN2020/110066
Other languages
English (en)
Chinese (zh)
Inventor
林群婷
张萌
刘丽春
曾立董
骆明杰
张娟
孙雷
Original Assignee
深圳市真迈生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳市真迈生物科技有限公司 filed Critical 深圳市真迈生物科技有限公司
Publication of WO2021114713A1 publication Critical patent/WO2021114713A1/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Definitions

  • the present invention relates to the field of molecular biology. Specifically, the present invention relates to a cell lysis solution, a cell lysis method, a method for building a library, and applications.
  • the construction of a sequencing library is a necessary step for sequencing to achieve abnormal detection of a small amount of cell chromosome data.
  • the gDNA obtained by cell lysis is a key factor that affects the success of the sequencing library.
  • cell lysis methods include alkaline lysis (the main component is NaOH), proteinase K lysis and so on.
  • the alkaline lysis method mainly uses NaOH to lyse cells, and the obtained gDNA has high requirements for the buffer in the subsequent library construction system. If the subsequent addition of reagents that can neutralize alkalinity, it is easy to increase the risk of contamination.
  • Proteinase K lysis method uses proteinase K to degrade proteins to achieve cell lysis.
  • Proteinase K is active in a wide pH range (pH 4-12.5), temperature range (37-60°C), higher salt concentration (such as 3M GuHCl) and denaturant (such as 4M urea); some detergents Agents such as Tween20 (5%), Triton X-100 (1%) or SDS (1%) and metal chelating agent EDTA etc. cannot inactivate proteinase K.
  • Ca 2+ can protect proteinase K from autolysis and increase its thermal stability, proteinase K is often stored in a buffer containing calcium ions (Ca 2+ ) or reacted in a buffer containing Ca 2+.
  • the inventors known reagent formulations that utilize proteinase K to digest proteins to achieve cell lysis, usually, also include other protease K activity or stability, and/or can act on cells including It is used as a component in the cell membrane or cell content to improve the effect of cell lysis.
  • the common proteinase K cell lysate also contains 0.5% SDS and 10mmol/L EDTA to enhance or stabilize the proteinase K enzyme activity.
  • SDS is a strong denaturant. Even a small amount of SDS will affect the activity of many proteases. For example, DNA fragmentation enzymes, transposases, etc.
  • Invented Man provides a cell lysis solution, a cell lysis method, and a library preparation method based on the cell lysis method.
  • the first aspect of the present invention provides a cell lysate, the active ingredients of the cell lysate are composed of proteinase K and NP-40.
  • the effective ingredient referred to here includes any substance that helps cell lysis, for example, a substance that helps to increase the activity of digestive enzymes, for example, a substance that can interact with proteins, lipids and other substances on the cell membrane, nuclear membrane, or genome.
  • the cell lysate has a simple composition and can effectively remove the protein on the genome to obtain the genomic DNA in the cell. Moreover, the lysed solution system does not need to be replaced or processed, and can be directly used for further detection of cell genomic DNA, such as sequencing.
  • the cell lysate may also have at least one of the following additional technical features.
  • the above-mentioned cell lysate is composed of proteinase K, NP-40 and H 2 O.
  • the proteinase K and NP-40 in the cell lysate are commercially available conventional reagents. It is understood that, preferably, the proteinase K, NP-40 and H 2 O used to prepare the cell lysate do not contain DNA polymerase and DNA. Fragmentation enzyme activity component.
  • the concentration of proteinase K in the cell lysate is 2 ng/mL to 200 ⁇ g/mL, and/or the volume percentage concentration of NP-40 is 1% to 10%.
  • the cell lysates with different concentrations of proteinase K and NP-40 were tested.
  • the cell lysate can effectively lyse the cells at the time of mL and 10%, 200 ⁇ g/mL and 1%, 1 ⁇ g/mL and 5%, 100ng/mL and 1%, 100 ⁇ g/mL and 10%.
  • the concentration of proteinase K in the cell lysate is 0.002-1 ⁇ g/mL or the concentration of proteinase K is 0.002-0.1 ⁇ g/mL, which can also ensure that cells are effectively lysed, and can further reduce the cost of the cell lysate.
  • the cell lysate in any of the above embodiments has a simple composition, can effectively lyse cells, and is particularly suitable for the lysis of a small number of animal cells (1 to 200 cells), and the components in the lysate do not affect subsequent reactions, such as nucleic acid fragmentation reactions. , Amplification reaction.
  • the genome coverage in the result of database construction and sequencing is 99.54%. It can be seen that the use of any of the above cell lysates can effectively remove chromosomes. The protein on the chromosome to remove the influence of the protein on the sequencing.
  • the second aspect of the present invention provides a cell lysis method, which comprises using the cell lysis solution in the first aspect or any of the embodiments to lyse cells.
  • a cell lysis method which comprises using the cell lysis solution in the first aspect or any of the embodiments to lyse cells.
  • the cells in the cell lysis method are animal cells, the number of cells is 1-200, and the number of cells in an example is 1-10.
  • the cell lysis method performs lysis at 55°C to 65°C, and/or the lysis time is 30min to 60min.
  • the cell lysis method further includes adding a termination reaction solution to terminate the lysis.
  • the types of the termination reaction solution include protease inhibitors, which are used to terminate the activity of proteinase K, such as PMSF (phenylmethyl sulfonyl fluoride), antipain (anti-protease peptide), etc.
  • the termination reaction solution added is In PMSF aqueous solution, in order to avoid the influence of protease inhibitors on subsequent experiments, the PMSF concentration as the termination reaction solution should not be too high.
  • the final concentration of the termination reaction solution selected is 0.5 mM ⁇ 1 mM, and the final concentration is the termination reaction solution to terminate the lysis The reaction concentration during the reaction.
  • the above cell lysis method has simple reaction conditions and convenient operation, can effectively lyse a small amount of animal cells to obtain genomic DNA, and the components in the cell lysis solution and the termination reaction solution do not affect DNA fragmentation and amplification, and the lysed cell solution can be used directly For follow-up experiments.
  • the third aspect of the present invention provides a nucleic acid preparation method, which includes obtaining cell nucleic acid by using the cell lysis method in the second aspect or any of the examples of the present invention.
  • the nucleic acid is DNA and/or RNA of the cell.
  • the nucleic acid is DNA.
  • the DNA prepared by this method has no protein on it, and can be directly used to prepare a DNA library without purification to remove the cell lysate and stop the reaction solution.
  • the above description of the technical features and advantages of the cell lysis method in the second aspect of the present invention or any of the embodiments is also applicable to the nucleic acid preparation method.
  • the fourth aspect of the present invention provides a nucleic acid library preparation method, which includes the steps of: obtaining a nucleic acid using the nucleic acid preparation method in the third aspect or any example of the present invention; and fragmenting the nucleic acid.
  • the nucleic acid library preparation method further includes amplifying the fragmented nucleic acid to obtain the nucleic acid library.
  • the fragmentation or separation operation there is no purification or separation operation between the steps of the method, that is, there is no purification or separation operation after the steps of obtaining the nucleic acid and fragmenting the nucleic acid respectively, and adding the fragment reagent after obtaining the nucleic acid to perform the fragmentation treatment ,
  • the fragmented product is directly used for amplification.
  • a fragmentation reagent is used to perform the fragmentation.
  • the nucleic acid is DNA
  • the fragmentation reagent is used to fragment the DNA. It can be understood that there are many methods for fragmenting DNA, such as ultrasonic interruption and DNA fragmentation reagent interruption.
  • the DNA fragmentation reagent includes transposase complexes, DNA interruption enzymes, and the like. For DNA obtained from a small number of cells, it is preferable that a DNA fragmentation reagent fragments the DNA.
  • DNA fragmentation enzymes can be selected from Tiangen DNA Fragmentation Kit NG305-02, Qiagen CM0162 Fragmentase Kit, NEB Fragmentase and other endonucleases or combinations of endonucleases capable of fragmenting DNA, etc.; transposition Enzyme complexes include Tn transposition complex, Mu transposition complex and other complexes with transposition function.
  • the transposase complex is Tn transposition complex, specifically Tn5 transposase complex body.
  • the Tn5 transposase complex is a complex formed by Tn5 transposase and a transposable linker.
  • the transposable linker consists of a Tn5 transposase recognition sequence or a Tn5 transposase recognition sequence and a known PCR primer for recognition. The sequence composition.
  • the nucleic acid library preparation method described above is to obtain nucleic acid by using the nucleic acid preparation method provided in the third aspect of the present invention or any example.
  • the above description of the technical features and advantages of the nucleic acid preparation method in the third aspect of the present invention or any example also applies The nucleic acid library preparation method.
  • the termination reaction solution is added to the original reaction tube to terminate the lysis reaction to obtain nucleic acid; in the same reaction tube, a fragmentation reagent is added to fragment the nucleic acid; in the same reaction tube, the expansion is added
  • the amplification reagent is used for amplification to obtain a nucleic acid library. There is no purification operation or separation operation between the steps of the method, and the reaction in each step is carried out in the same reaction tube. It can be seen from the experimental results that the cell lysate and termination reaction solution do not affect the effect of the fragmentation reagent and the amplification effect.
  • this nucleic acid library preparation method it takes about 3.5 hours from cell lysing to obtaining a DNA library; a nucleic acid library preparation method including two amplification and multiple purification steps is used to obtain a nucleic acid library (lysing cells to obtain nucleic acid; MDA (multiplex) Displacement amplification) technology to amplify the nucleic acid obtained by cell lysis; fragment nucleic acid; purify the fragmented product; PCR amplify the purified product; purify the PCR amplified product to obtain a nucleic acid library.), it takes about 16 hours, and the time used is about this
  • the nucleic acid preparation method provided in the fourth aspect of the invention or any of the embodiments takes 5 times the time.
  • the nucleic acid preparation method provided in the fourth aspect or any of the embodiments of the present invention is simple and rapid in operation, and the library prepared by this method can be used for sequencing.
  • the fifth aspect of the present invention provides a sequencing method, which includes using the nucleic acid library prepared in the fourth aspect or any example of the present invention for sequencing to obtain a sequencing result.
  • the nucleic acid obtained by the cell lysis method in any of the above examples can be used to construct libraries of different sequencing platforms, such as Illumia's MiSeq and HiSeq sequencing platforms (HiSeq-2500, Hiseq-2000, NextSeq 500, HiseqX10 and other sequencers), PacBio sequencing Platforms (PacBio RS series, Sequel series sequencers), BGI gene sequencing platforms (MGISEQ-2000, MGISEQ-200, BGISEQ-500, DNBSEQ-T7 and other sequencers), etc.
  • Illumia's MiSeq and HiSeq sequencing platforms HiSeq-2500, Hiseq-2000, NextSeq 500, HiseqX10 and other sequencers
  • PacBio sequencing Platforms PacBio RS series, Sequel series sequencer
  • the nucleic acid is obtained by the cell lysis method in any of the above embodiments, or the nucleic acid library constructed in any example is sequenced using the sequencing platform built by the inventor, and CNV mutations of not less than 1M can be detected, and the sequencing result
  • the GC bias and MAD (Median Absolute Deviation) in GC are lower than those in the sequencing results obtained by using a nucleic acid library preparation method including two amplification and multiple purification steps to obtain a nucleic acid library and sequencing using a high-throughput sequencing platform.
  • a nucleic acid library preparation method including two amplification and multiple purification steps includes: cell lysis to obtain nucleic acid; MDA technology to amplify nucleic acid obtained from cell lysis; fragmentation of nucleic acid; purification of fragmented products; PCR amplification and purification of purified products; The PCR product was amplified to obtain a nucleic acid library.
  • the IlluminaHiSeqX10 high-throughput sequencing platform is used for high-throughput sequencing.
  • the sequencing platform built by the inventor refers to CN201610209150.2, CN201710607295.2, CN201610958047.8, CN201710607306.7, CN201620278363.6, CN201520614342.2, CN201520614143.1, CN201520614143.1, CN201711105069.0 and/or CN201621419140.3.
  • the operation process can be performed by referring to https://doi.org/10.1371/journal.pone.0188181(Single molecule sequencing of the M13 virus genome without amplification), for example.
  • the sixth aspect of the present invention provides a kit, which contains the cell lysate in the first aspect or any of the examples of the present invention.
  • the active ingredients of the cell lysate in the kit can be stored in different forms, such as proteinase K and NP-40 separately stored in high concentration form, or stored in high concentration form after the two ingredients are mixed, or after mixing Store in a suitable concentration form.
  • the two substances are configured into a mixture of appropriate concentrations, where the appropriate concentration refers to the concentration of proteinase K at 2ng/mL ⁇ 200 ⁇ g/mL, the volume percentage concentration of NP-40 is 1%-10%; high concentration means that the concentration of one or both of the two substances is higher than the highest value of the respective suitable concentration.
  • the above kit further includes a termination reaction solution, and the termination reaction solution is used to terminate the cell lysis reaction.
  • the termination reaction solution can be a protease inhibitor, such as PMSF (phenylmethylsulfonyl fluoride), antipain (anti-protease peptide), etc., to terminate the activity of proteinase K.
  • the termination reaction solution provided by the kit is PMSF.
  • the concentration of PMSF provided in the kit is not less than 5mM, or the PMSF provided in the kit is solid, and when used, it is configured as an aqueous solution of PMSF with a concentration of not less than 5mM.
  • the above kit further includes a nucleic acid fragmentation reagent, which is used to fragment the nucleic acid or to fragment the nucleic acid while adding a known sequence to both ends or ends of the fragmented nucleic acid.
  • the types of nucleic acid fragmentation reagents include transposase complexes, DNA disrupting enzymes and so on. For small amounts of DNA ( ⁇ 50ng), it is preferred that DNA fragmentation reagents fragment the DNA.
  • DNA fragmentation enzymes can be selected from Tiangen DNA Fragmentation Kit NG305-02, Qiagen CM0162 Fragmentase Kit, NEB Fragmentase and other endonucleases or combinations of endonucleases capable of fragmenting DNA, etc.; transposition The enzyme complex is selected from Tn transposition complex, Mu transposition complex and other complexes with transposition function.
  • the DNA fragmentation reagent is the Tn5 transposase complex
  • the Tn5 transposase complex is a complex formed by the Tn5 transposase and the transposable linker
  • the transposable linker is composed of the Tn5 transposase recognition sequence or Tn5 transposase recognition sequence and a known sequence for PCR primer recognition.
  • the cell lysis solution and the termination reaction solution do not affect the effect of the fragmentation reagent and the amplification effect, and the nucleic acid obtained after cell lysis does not need to be purified and can be directly used for nucleic acid library construction.
  • Using this kit to construct a library can be done from cell lysis to amplification. The reaction is carried out in a reaction tube without the need to replace the reaction tube.
  • the use of this kit to construct a nucleic acid library on the one hand simplifies the operation steps and reduces the cost, on the other hand, reduces the loss of DNA, and is suitable for library construction with a small number of samples.
  • the description of the advantages of the cell lysis solution, cell lysis method, nucleic acid preparation method, and nucleic acid library preparation method in any of the above embodiments is also applicable to the kit.
  • the seventh aspect of the present invention provides the application of the kit in a method or device involving cell lysis, including application to preimplantation genetic screening of embryos.
  • the results of preimplantation genetic screening using this kit are consistent with the results of preimplantation genetic screening using high-throughput sequencing, which can detect chromosomal mutations of CNV (copy number variation) not less than 1M .
  • the cell lysate provided in any aspect or embodiment of the present invention has a simple composition and can effectively remove proteins on the genome, and the lysed cell solution is directly used for DNA library construction without purification.
  • the cell lysis method using the cell lysate can quickly obtain genomic DNA.
  • the library preparation method using the cell lysate can quickly prepare a DNA library, and the prepared library can meet the requirements of different sequencing platforms.
  • the cell lysis method, library construction method, sequencing method, etc., using the cell lysate provided in any of the foregoing embodiments are particularly suitable for clinical use due to simple operations.
  • Figure 1 shows the detection result of the Chinese library of Example 2 by LabChip GX Touch (PerkinElmer) microfluidic capillary electrophoresis;
  • Figure 2 shows the detection result of the Chinese library of Example 3 by LabChip GX Touch (PerkinElmer) microfluidic capillary electrophoresis;
  • Figure 3 shows the detection result of the Chinese library of the comparative example by LabChip GX Touch (PerkinElmer) microfluidic capillary electrophoresis;
  • Figure 4 shows the agarose electrophoresis detection diagram of the amplified product 1 in the comparative example
  • Figure 5 shows the sequencing and analysis results of chES497 samples on the single-molecule sequencing platform built by Illumina HiseqX10 and the inventor;
  • Figure 6 shows the sequencing analysis results of chES497 samples on the single-molecule sequencing platform built by Illumina HiseqX10 and the inventor.
  • the cell lines used in Examples 2, 3 and 4 are 90-P50 And chES497(46,XX,del(1p36.33-1p36.32)1.29M, dup(16p13.3-16.13.11)16.72M) were all from Hunan Guangxiu Hospital.
  • the "high-throughput sequencing” referred to in this article refers to the ability to sequence hundreds of thousands to millions of nucleic acid molecules in parallel at a time.
  • the GC bias (GC preference) value in the sequencing data is an important indicator for judging the effect of sequencing.
  • the lower the GC bias the lower the GC bias introduced during library construction and sequencing.
  • the difference between DNA molecules with different GC composition and rich GC or less The bias of chromosome sequencing data containing GC is reduced.
  • the MAD (Median Absolute Deviation) in sequencing data is the same as the conventional definition of MAD.
  • For sequencing data it refers to the median of the absolute value of the new data obtained by subtracting the median from the original data, which is used to measure the data.
  • the smaller the MAD value the lower the degree of dispersion of the measured data, the more concentrated the distribution of data without anomalies, and the easier to distinguish discrete data.
  • the concentration of NP-40 refers to the volume percentage concentration of NP-40 in the cell lysate.
  • the concentration of proteinase K refers to the concentration of proteinase K in the cell lysate.
  • the kit contains tube 1, which is a cell lysate.
  • the active ingredients of the cell lysate are composed of proteinase K and NP-40.
  • the concentrations of the two are 2ng/mL ⁇ 200 ⁇ g/mL and 1% ⁇ 10%, respectively. 1% ⁇ 10% is the volume percentage concentration.
  • the cell lysates with different concentrations of proteinase K and NP-40 were tested.
  • Proteinase K and NP-40 in the kit are conventional commercially available reagents, such as NP-40 with Sigma's article number 74385, and Merck Millipore's article number 539480-100mg Proteinase K.
  • the two reagents do not contain DNase activity and have no other influence. Enzymatically active substances exist, such as SDS and so on.
  • the two active ingredients proteinase K and NP-40 contained in the cell lysate are stored in high concentrations respectively.
  • the cell lysate mix the two substances into a mixture of appropriate concentration; in another case Next, the cell lysate is stored in the form of a high-concentration mixture.
  • the high-concentration mixture is diluted with deionized water to a suitable concentration mixture.
  • the appropriate concentration means that the concentration of proteinase K is 2ng ⁇ 200 ⁇ g/mL, and the volume percentage concentration of NP-40 is 1% ⁇ 10%.
  • a high-concentration mixture means that the concentration of one or both of the two substances is higher than the appropriate concentration.
  • the kit further includes a tube 2, which is a termination reaction solution, and the termination reaction solution is used to terminate the activity of proteinase K.
  • the terminating reaction solution can be a protease inhibitor, such as PMSF (phenylmethylsulfonyl fluoride), antipain (anti-protease peptide) and so on.
  • the concentration of the PMSF aqueous solution in tube 2 is not less than 5 mM, and the final concentration when used is 0.5 mM to 1 mM, that is, the concentration of the PMSF aqueous solution is 0.5 mM to 1 mM when the PMSF aqueous solution is added to the cell lysis solution to terminate the cell lysis reaction.
  • kit containing tube 1 and tube 2 to lyse animal cells to obtain DNA in the cells.
  • the kit has simple components and convenient operation for understanding cells, and can effectively lyse cells to obtain DNA.
  • the obtained DNA is directly used for library construction without purification. This operation avoids the problem that the amount of nucleic acid is reduced after the nucleic acid of a small number of cells is purified.
  • This kit is suitable for DNA extraction from single cell/micro cell samples or preimplantation genetic screening samples.
  • the kit further includes tube 3, which is a DNA fragmentation reagent.
  • the types of fragmentation reagents can include transposase complexes, DNA interrupting enzymes, etc., and the DNA interrupting enzymes can be selected from Tiangen DNA Fragmentation kit NG305-02, Qiagen CM0162 fragmentation enzyme kit or NEB fragmentation enzyme; transposase complex can choose Tn transposition complex, Mu transposition complex, etc.
  • the DNA fragmentation reagent of tube 3 is a Tn5 transposase complex.
  • the Tn5 transposase complex is a complex formed by connecting Tn5 transposase and a transposable linker.
  • the sequence of the transposable linker is determined by Tn5.
  • the recognition sequence is composed of a Tn5 recognition sequence and a known sequence for PCR primer recognition.
  • the DNA obtained after cell lysis can be constructed without purification.
  • the cell lysate and termination reaction solution have no effect on fragmentation reagents, especially for Tn5 transposase complexes. influences.
  • the reaction is carried out in a reaction tube, which can simplify the operation steps and reduce the cost on the one hand, and reduce the loss of DNA on the other hand.
  • the kit also includes amplification reagents and purification reagents.
  • This example provides the application of the kit in Example 1 in library construction and sequencing on the Illumina company's high-throughput sequencing platform.
  • a small amount of cells (1 to 200 cells) can be separated by techniques such as micromanipulators and mouth pipettes, and a small amount of 90-P50 (chHES90, 46, XY, source: CITIC Xiangya Reproductive and Genetic Hospital)
  • a sample of normal cells (1 to 200 cells) contains PBS (pH 7.2 to 7.4), and the total volume does not exceed 4 ⁇ L.
  • Example 2 Take 6 ⁇ L of the cell lysate prepared in Example 1 and add it to the cell sample to mix, and incubate at 55°C to 65°C for 30 to 60 minutes.
  • the proteinase K and NP-40 concentrations of the cell lysate used in this example are 1 ⁇ g/ mL and 5%, 100ng/mL and 1%, 2ng/mL and 1%, the selected three combinations of cell lysates can effectively lyse cells.
  • Example 2 and Examples 3 The proteinase K and NP-40 concentrations of the cell lysate used were 100ng/mL and 1%, respectively.
  • the termination reaction solution PMSF phenylmethylsulfonyl fluoride
  • the final concentration of PMSF is 0.5mM-1mM
  • the reaction is at room temperature for 15min ⁇ 35min to obtain the cleavage product.
  • the library was constructed with the reagents of Nanjing Novozan kit (Cat NO.S111-C3, Vazyme), and the specific steps are as follows:
  • Nanjing Novozan kit (Cat NO.S111-C3, Vazyme) reagents to fragment the lysate in step 3) of cell lysis, and add 4 ⁇ L of 5 ⁇ fragmentation buffer to the lysate to fragment the complex.
  • C3 1 ⁇ L add water to 20 ⁇ L, mix well, place in a PCR machine, incubate at 37°C ⁇ 55°C for 10 ⁇ 30min, add 5 ⁇ L of stop reaction buffer after the reaction, mix well, and react at room temperature for 5 ⁇ 7min.
  • the PCR reagents are the reagents in the Nanjing Novozan kit (Cat NO.S111-C3, Vazyme), and the PCR reaction system contains 5 ⁇ TAB amplification buffer Solution 10 ⁇ L, TAE 1 ⁇ L, primer 12 ⁇ L, primer 22 ⁇ L, make up to 50 ⁇ L with water, mix well, and place in a preheated PCR machine.
  • the PCR amplification process settings are shown in Table 1.
  • the PCR product was purified using Nanjing Novozan's Purification Magnetic Bead Kit (Cat NO.N411-03, Vazyme). If the PCR product system is less than 50 ⁇ L, add water to make up to 50 ⁇ L, and then perform two rounds of purification. The first round of purification uses 35 ⁇ L 0.7 ⁇ VAHTS DNA Clean Beads (0.7 ⁇ purified magnetic beads), and the second round uses 7.5 ⁇ L 0.15 ⁇ VAHTS DNA Clean Beads (0.15x purified magnetic beads). Purification was carried out in accordance with the instruction manual or the conventional purification steps of magnetic bead purification, and the final elution volume was 20 ⁇ L to obtain the DNA library.
  • Figure 1 shows the detection result of the library by the LabChip GX Touch bioanalyzer.
  • the abscissa is the fragment length
  • the unit is BP
  • the ordinate is the fluorescence intensity
  • the concentration of the library is reflected.
  • Sequencing results show that the total amount of unqiue data obtained (the total amount of uniquely compared data) is about 614.98M, and the coverage of the genome is as high as 99.54% when the sequencing depth of the DNA library constructed by this method is 30.75 ⁇ . GC bias is 0.06. From the sequencing results, the coverage of the genome is as high as 99.54%. It can be judged that using the cell lysate in the example to lyse cells can effectively remove the proteins on the genome, thereby avoiding the influence of the proteins on the genome on fragmentation and the sequencing results. For the impact of coverage, the specific sequencing results are shown in Table 2.
  • This example is the application of the kit in Example 1 in cell lysis, library construction and single molecule sequencing platforms.
  • the operation flow can refer to https://doi.org/10.1371/journal.pone.0188181(Single molecule sequencing of the M13 virus genome without amplification).
  • a small number of cell samples can be separated by techniques such as micromanipulators and mouth pipettes to obtain 5-10 CNV (copy number variation) cell lines chES497(46,XX,del(1p36.33-1p36.32)1.29M, dup(16p13.3-16.13.11)16.72M) (Source: CITIC Xiangya Reproductive and Genetic Specialist Hospital), and place the cells in 1-4 ⁇ L PBS (pH7.2 ⁇ 7.4) solution to obtain cell samples.
  • CNV copy number variation
  • Example 2 Take 6 ⁇ L of the cell lysate prepared in Example 1 and add it to the cell sample for mixing, and incubate at 55°C to 65°C for 30min to 60min.
  • the cell lysate proteinase K and NP-40 concentrations used in this example are 100ng/mL and 1 %.
  • the termination reaction solution (PMSF, phenylmethylsulfonyl fluoride) to the solution in step 2), the final concentration of PMSF is 0.5 mM to 1 mM, and the reaction is kept at room temperature for 15 to 35 minutes to obtain the cleavage product.
  • PMSF phenylmethylsulfonyl fluoride
  • GeneMind Biotech full name: Shenzhen GeneMind Biotech Co., Ltd.
  • single-cell whole genome amplification kit Cat NO.C0BD01-01AA, GeneMind Biotech
  • the PCR reaction system includes 5 ⁇ PCR amplification buffer 10 ⁇ L, 1U/ ⁇ L and PCR amplification enzyme 1 ⁇ L, primer 12 ⁇ L, primer 20.2 ⁇ L, supplemented with water To 50 ⁇ L, mix well, and place in a pre-heated PCR machine.
  • the PCR amplification process settings are shown in Table 3.
  • the PCR products were purified with Nanjing Novozan's Purification Magnetic Bead Kit (Cat NO.N411-03, Vazyme). If the PCR product system is less than 50 ⁇ L, add water to make up to 50 ⁇ L, and then perform two rounds of purification. The first round of purification uses 35 ⁇ L 0.7 ⁇ VAHTS DNA Clean Beads (0.7 ⁇ purified magnetic beads), and the second round uses 7.5 ⁇ L 0.15 ⁇ VAHTS. DNA Clean Beads (0.15x purified magnetic beads). Purification was carried out in accordance with the instructions in the manual or the conventional purification steps of magnetic bead purification. The final elution volume was 20 ⁇ L to obtain the DNA library.
  • FIG. 2 shows the detection result of the library by the Bioanalyzer LabChip GX Touch.
  • the abscissa is the fragment length
  • the unit is BP
  • the ordinate is the fluorescence intensity
  • the concentration of the library is reflected.
  • chES497-GC DNA library constructed from cell samples in Example 3, using the single molecule sequencing platform built by the inventor for sequencing
  • chES497-NGS DNA library constructed from cell samples in Example 3, using Illumina HiseqX10 sequencing platform Perform sequencing.
  • This comparative example is a comparative experiment of Example 3.
  • This comparative example and Example 3 use the same cell sample, and use different cell lysis methods, library construction methods and sequencing platforms to perform library construction and sequencing on the cell samples.
  • This comparative example is a method commonly used by PGS at present.
  • the current preimplantation screening method is to use 3 to 5 cells of the blastocyst trophoblast as the biopsy material, and then through various genetic screening methods, such as fluorescence in situ hybridization (Fish), polymerase chain reaction (PCR) Screening for chromosomal abnormalities.
  • Fish fluorescence in situ hybridization
  • PCR polymerase chain reaction
  • the detection performance needs to achieve the detection rate of chromosomal abnormalities corresponding to the positive reference product with an abnormal fragment size greater than 4M to reach 100%, and the detection rate of chromosome abnormalities corresponding to the positive reference product with the abnormal fragment size less than or equal to 4M to reach more than 30%.
  • a small number of cell samples can be separated by techniques such as micromanipulators and mouth pipettes to obtain 5-10 CNV (copy number variation) cell lines chES497(46,XX,del(1p36.33-1p36.32)1.29M, dup(16p13.3-16.13.11)16.72M) (Source: CITIC Xiangya Reproductive and Genetic Specialist Hospital), and place the cells in 1-4 ⁇ L PBS (pH7.2 ⁇ 7.4) solution to obtain cell samples, Subsequently, Discover-sc single-cell kit (Cat no. N601-02, Vazyme) was used for cell lysis and library construction.
  • CNV copy number variation
  • reaction mixture (as shown in Table 5) prepared in advance to the 10 ⁇ L cell lysate of step 2), mix and centrifuge briefly, and incubate at 30°C for 6 hours.
  • the amplified product 1 was diluted 10-fold, and the Qubit TM dsDNA BR Assay Kit concentration detection (CatNo. Q32853, Invitrogen Biotech.) and 1% agarose electrophoresis detection were performed respectively.
  • Figure 4 is the result of agarose electrophoresis detection of amplified product 1.
  • Marker 1 in the figure is a 50bp Marker; 2 is amplified product 1 with a total load of about 150 ng; 3 is amplified product 1 with a total load of about 180 ng; 4 is the negative control group (H 2 O).
  • the results show that the amplification products can be successfully obtained by using MDA technology.
  • kit TruePrep DNA Library Prep Kit V2 for Illumina (Cat NO.TD501, Vazyme) to fragment the amplified product 1.
  • the specific operation is: take 50ng of the amplified product 1 and add 4 ⁇ L 5 ⁇ TTBL, 1.5 ⁇ L TTE MixV50, replenish water To 20 ⁇ L, mix well, place in a PCR machine, and incubate at 55°C for 10 min to obtain a fragmented product.
  • the PCR reaction system contains 10 ⁇ L 5 ⁇ TAB, 1 ⁇ L TAE, 5 ⁇ L N5-XX (XX means label position number), 5 ⁇ L N7-XX (XX means label position number), 5 ⁇ L PPM, replenishment To 50 ⁇ L, mix well, and place in a pre-heated PCR machine.
  • the PCR amplification process settings are shown in Table 6.
  • PCR product was purified using Nanjing Novozan's Purification Magnetic Bead Kit (Cat NO.N411-03, Vazyme). If step 5) PCR product system is less than 50 ⁇ L, make up to 50 ⁇ L, and then perform two rounds of purification. The first round of purification uses 0.7 ⁇ VAHTS DNA Clean Beads (0.7 ⁇ purified magnetic beads), and the second round of purification uses 7.5 ⁇ L 0.15 ⁇ VAHTS DNA Clean Beads (0.15x purified magnetic beads). Purification steps were carried out in accordance with the instruction manual or the conventional purification steps of magnetic beads, and the final elution volume was 20 ⁇ L to obtain the DNA library.
  • the obtained DNA library was tested with Qubit dsDNA BR Assay Kit (Cat No. Q32853, Invitrogen Biotech.) for concentration detection and LabChip GX Touch (PerkinElmer) for microfluidic capillary electrophoresis detection.
  • the main band size of the detected DNA library nucleic acid fragments was 250 ⁇ 450bp or so.
  • Figure 3 shows the detection result of the library by the Bioanalyzer LabChip GX Touch.
  • the abscissa is the fragment length, the unit is BP, the ordinate is the fluorescence intensity, and the library concentration is detected.
  • the sequencing results showed that the total amount of unique data (the total amount of uniquely aligned data) obtained by sequencing the DNA library constructed by this method was 4.9M, and the coverage (genome coverage) was 13.31%.
  • the data quality and analysis results obtained by this method The specific results are shown in Table 4.
  • the sequencing results were analyzed using hg19 (normal human chromosome, the complete sequence can be downloaded from ftp://hgdownload.cse.ucsc.edu/goldenPath/hg19/chromosomes/ website) as a reference genome for analysis.
  • the chES497 samples were detected and analyzed according to different cell lysis methods, library construction methods, and sequencing methods.
  • the two sequencing platforms used were Illumina HiseqX10 and the single-molecule sequencing platform built by the inventor.
  • Figures 5 and 6 show the sequencing analysis results of chES497 samples on the single-molecule sequencing platform built by Illumina HiseqX10 and the inventor. The results show that the detection and analysis results of the two sequencing platforms are consistent.
  • Figure 5 shows that both platforms can detect about 1M CNV (copy number variation)
  • the chES497-NGS marked on the upper right of the figure is the sequencing analysis result of the Illumina HiseqX10 library
  • the chES497-GC marked on the lower right is the sequencing result of the single molecule sequencing platform built by the inventor.
  • the abscissa is the position of the chromosome
  • the ordinate is log2 (normalize bin depth), that is, the ordinate is log2 (standardized window depth)
  • the arrow mark is the position of the chromosome CNV in the chromosome;
  • Figure 6 shows that both platforms can detect larger than 10M CNV (copy number variation)
  • the chES497-NGS marked on the upper right of the figure is the sequencing analysis result of the Illumina HiseqX10 library
  • the chES497-GC marked on the lower right is the sequencing result of the single molecule sequencing platform built by the inventor.
  • the abscissa is the position of the chromosome
  • the ordinate is log2 (normalize bin depth)
  • that is, the ordinate is log2 (normalized window depth)
  • the arrow mark is the position of the chromosome CNV in the chromosome.
  • the sequencing results can be used to analyze the CNV of the cells.
  • the size of CNV detected is greater than 10M, and some are about 1M.
  • the detection result is consistent with the result of HiseqX10 detection and meets the PGS detection standard. Therefore, using the kit in Example 1 of the present invention for cell lysis and the single molecule sequencing platform built by the inventor for sequencing can be used for PGS (preimplantation genetic screening).
  • the traditional PGS library building process takes about 16 hours to build the library, while the use of the kit in Example 1 of the present invention for cell lysis and library building takes about 3.5 hours, so Using the method of lysing library construction in the embodiment of the invention can greatly shorten the detection time.
  • Table 4 the GC bias (GC preference) of the sequencing results of the two methods is different.
  • the GC bias of the single-molecule sequencing platform built by the inventor is obvious when the kit in Example 1 of the present invention is used for cell lysis to build a database. Lower than the sequencing result of HiseqX10 library construction; meanwhile, the MAD (median absolute deviation) of the sequencing results of the two methods is different.
  • the MAD of the cell lysis library construction sequencing using the kit in Example 1 of the present invention is significantly less than the sequencing result of HiseqX10 library construction , The smaller the value, the easier it is to analyze the missing chromosomes from the detection results.
  • the position indicated by the arrow is the position of CNV.
  • the sequencing result (chES497-NGS) in the example the position of CNV is still around. There are other sites that affect the judgment of CNV.
  • the position of CNV in the sequencing result (chES497-GC) in Example 3 is obvious and easy to judge.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne une solution de lyse cellulaire, un kit et une application, comprenant un procédé de lyse cellulaire, un procédé de construction de bibliothèque et une application associée. La solution de lyse cellulaire est composée de protéinase K et de NP-40, a une composition simple, et peut lyser efficacement des cellules et éliminer les protéines sur les chromosomes. La solution d'acide nucléique après lyse peut être directement utilisée pour des réactions ultérieures telles que la construction de bibliothèque d'ADN, sans être soumise à un quelconque traitement. Le procédé de lyse cellulaire et le procédé de préparation de la bibliothèque de la solution de lyse cellulaire peuvent être utilisés pour préparer rapidement une bibliothèque d'ADN. La préparation de la bibliothèque est rapide, la bibliothèque préparée peut être utilisée pour différentes plateformes de séquençage, et la conversion génique biaisée (GC biais) des données de séquençage obtenues n'est pas significative. De plus, le kit peut également être appliqué à un criblage génétique de préimplantation basé sur le séquençage (PGS).
PCT/CN2020/110066 2019-12-09 2020-08-19 Solution de lyse cellulaire, kit et application WO2021114713A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911247526.9A CN113025608A (zh) 2019-12-09 2019-12-09 细胞裂解液、试剂盒及应用
CN201911247526.9 2019-12-09

Publications (1)

Publication Number Publication Date
WO2021114713A1 true WO2021114713A1 (fr) 2021-06-17

Family

ID=76329466

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/110066 WO2021114713A1 (fr) 2019-12-09 2020-08-19 Solution de lyse cellulaire, kit et application

Country Status (2)

Country Link
CN (1) CN113025608A (fr)
WO (1) WO2021114713A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113528507A (zh) * 2021-07-12 2021-10-22 中国农业科学院作物科学研究所 一种高通量快速磁珠法提取鸡血基因组dna的试剂盒及提取法
CN114350653A (zh) * 2021-12-29 2022-04-15 武汉赛维尔生物科技有限公司 一种动物组织裂解与直接pcr扩增的方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113755485A (zh) * 2021-09-14 2021-12-07 国青(浙江)科学研究有限公司 一种具有多功能试剂组的无毒型质粒提取试剂盒及质粒提取方法
CN117106772B (zh) * 2023-10-25 2024-01-26 青岛金域医学检验实验室有限公司 一种用于病毒核酸检测的样本释放剂

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072228A2 (fr) * 2003-02-06 2004-08-26 Becton Dickinson And Company Methode de pretraitement pour l'extraction d'acide nucleique a partir d'echantillons biologiques et trousses associees
WO2006047481A2 (fr) * 2004-10-22 2006-05-04 Redpath Integrated Pathology, Inc. Amplifiabilite renforcee d'echantillons minimes de tissus traites au fixatif, echantillons cytologiques minimes colores, et autres sources minimes d'adn
CN101397588A (zh) * 2008-11-06 2009-04-01 昆明理工大学 一种采集、回收痕量dna的试剂及试剂盒和应用方法
CN101724696A (zh) * 2009-10-28 2010-06-09 吉林大学 双温多重pcr鉴定猪早期胚胎性别的方法及试剂盒
WO2011083429A1 (fr) * 2010-01-07 2011-07-14 Bigtec Private Limited Procédé pour isoler des acides nucléiques, et kit à cet effet
CN102534814A (zh) * 2012-01-18 2012-07-04 首都医科大学 全细胞水平高效捕获染色质转录调控区的新方法及其用途
CN105441421A (zh) * 2014-09-30 2016-03-30 深圳华大基因研究院 一种细胞裂解方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9519638D0 (en) * 1995-09-26 1995-11-29 Dynal As Method
CN104630209A (zh) * 2015-03-17 2015-05-20 中国烟草总公司郑州烟草研究院 一种无损伤冷抽提小型昆虫基因组dna的方法
CA2992717A1 (fr) * 2015-07-17 2017-01-26 President And Fellows Of Harvard College Procedes d'amplification de sequences d'acides nucleiques
KR20200123246A (ko) * 2018-05-18 2020-10-28 재단법인 아산사회복지재단 미토콘드리아 dna를 내부 기준 시료로 사용하는 마이코플라즈마 검출 방법

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072228A2 (fr) * 2003-02-06 2004-08-26 Becton Dickinson And Company Methode de pretraitement pour l'extraction d'acide nucleique a partir d'echantillons biologiques et trousses associees
WO2006047481A2 (fr) * 2004-10-22 2006-05-04 Redpath Integrated Pathology, Inc. Amplifiabilite renforcee d'echantillons minimes de tissus traites au fixatif, echantillons cytologiques minimes colores, et autres sources minimes d'adn
CN101397588A (zh) * 2008-11-06 2009-04-01 昆明理工大学 一种采集、回收痕量dna的试剂及试剂盒和应用方法
CN101724696A (zh) * 2009-10-28 2010-06-09 吉林大学 双温多重pcr鉴定猪早期胚胎性别的方法及试剂盒
WO2011083429A1 (fr) * 2010-01-07 2011-07-14 Bigtec Private Limited Procédé pour isoler des acides nucléiques, et kit à cet effet
CN102534814A (zh) * 2012-01-18 2012-07-04 首都医科大学 全细胞水平高效捕获染色质转录调控区的新方法及其用途
CN105441421A (zh) * 2014-09-30 2016-03-30 深圳华大基因研究院 一种细胞裂解方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113528507A (zh) * 2021-07-12 2021-10-22 中国农业科学院作物科学研究所 一种高通量快速磁珠法提取鸡血基因组dna的试剂盒及提取法
CN114350653A (zh) * 2021-12-29 2022-04-15 武汉赛维尔生物科技有限公司 一种动物组织裂解与直接pcr扩增的方法
CN114350653B (zh) * 2021-12-29 2024-03-29 武汉赛维尔生物科技有限公司 一种动物组织裂解与直接pcr扩增的方法

Also Published As

Publication number Publication date
CN113025608A (zh) 2021-06-25

Similar Documents

Publication Publication Date Title
WO2021114713A1 (fr) Solution de lyse cellulaire, kit et application
WO2018103025A1 (fr) Méthode de construction d'une banque de séquençage de cellule unique et son utilisation
US20210047635A1 (en) Transposase compositions for reduction of insertion bias
CN109415758B (zh) 使用含接头的经固定化的转座体进行的标签片段化
EP3192900B1 (fr) Procédé de construction d'une bibliothèque de composés cycliques d'acides nucléiques simple brin et réactifs associés
EP4183886B1 (fr) Procédé d'amplification d'acide nucléique
US20160177359A1 (en) Method for controlled dna fragmentation
US20230086170A1 (en) Method of nucleic acid enrichment using site-specific nucleases followed by capture
WO2016037418A1 (fr) Procédé de construction d'une bibliothèque de composés cycliques d'acides nucléiques simple brin et réactifs associés
WO2017084023A1 (fr) Procédé à débit élevé de création de bibliothèque pour profil de transcriptome de cellule individuelle
CN110886021B (zh) 一种单细胞dna文库的构建方法
WO2022021279A1 (fr) Support de co-marquage d'acides multinucleiques, son procédé de préparation et son application
WO2013056640A1 (fr) Procédé de préparation d'une banque d'acides nucléiques, ses utilisations, et kits associés
US20230056763A1 (en) Methods of targeted sequencing
AU2015217260A1 (en) Partitioning of DNA sequencing libraries into host and microbial components
WO2021253372A1 (fr) Construction de bibliothèque sans pcr à haute compatibilité et procédé de séquençage
CN110951827B (zh) 一种转录组测序文库快速构建方法及其应用
Fang et al. Depletion of ribosomal RNA sequences from single‐cell RNA‐sequencing library
CN106715691B (zh) 一种转座酶打断核酸并加接头的方法和试剂
CN111484992B (zh) 从含有甲醛的液基细胞学防腐剂中的样本分离核酸的方法
US10626444B2 (en) Methods of assaying nucleic acids of low quantities using a buffer nucleic acid
CN118284703A (zh) 胚胎核酸分析
WO2023215524A2 (fr) Amplification dirigée par modèle primaire et méthodes associées
CN107075560B (zh) 一种核酸的转座酶打断一站式处理方法及试剂

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20899999

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20899999

Country of ref document: EP

Kind code of ref document: A1